By Maegan Dube
2 minute read
October 26, 2020
Watch this on-demand webinar with Dr. Jonker, PhD, and our clinical nurse Gwen McComy, RN, BSN as they discuss options in two-layer compression systems. The webinar also covers the results from a recent clinical study conducted and published in BJCN assessing two-layer compression with and without Calamine to determine patient preference.
Previously recorded on Tuesday,
November 3, 11:30 AM ET
A recent study out of the UK compared AndoFlex®* TLC
Calamine and Coban2®** for patient comfort and preference (related
to degree of itchiness) and pruritus symptomology.
- 39 patients enrolled and randomized, 35 completed the
- Patients wore either Normal (35-40 mmHg) or Lite (25-30
mmHg) AndoFlex TLC Calamine or Coban2 for 6 weeks (2 phases of 3 weeks,
one phase of each compression type).
- Eligibility Criteria: 18 years or older, clinically
diagnosed with chronic venous insufficiency (CVI), and CEAP
(classification system for chronic venous disorders) clinical score of C2
Click here to register and receive the link to the
As seen in
the June 2020 issue of BJCN
*AndoFlex TLC Calamine also known as CoFlex TLC Calamine is a registered trademarks of Andover Healthcare, Inc., a subsidiary of Milliken Healthcare Products, LLC.
**Coban2 is a registered trademark of 3M.